LL-37 has no marketing authorisation. Early-phase clinical trials have been conducted: a Phase I/II study of intratumoral injection in melanoma reported local tumour regression; Phase II trials in ...
View full compound profile →Vendors stocking
3
across 2 countries
Total listings
3
2 in stock
Median price per mg
$76.90
Most common size
5mg
2 listings
Stock health
67%
2 vendors · 2 listings
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 3 vendor websites across 2 countries
